本文已被:浏览 766次 下载 596次
Received:October 12, 2019 Published Online:June 20, 2020
Received:October 12, 2019 Published Online:June 20, 2020
中文摘要: 目的 探讨具有骨肉瘤分化的乳腺肿瘤的临床病理特征、免疫组化表达、诊断和鉴别诊断。方法 对广西中医药大学第一附属医院病理科4例具有骨肉瘤分化的乳腺恶性肿瘤、经乳腺根治术切除的标本,进行HE和免疫组化染色,结合临床资料分析并文献复习。结果 光镜:4例患者中恶性叶状肿瘤伴骨肉瘤分化2例,化生性癌伴骨肉瘤分化1例,乳头状瘤伴骨肉瘤分化1例。免疫组化:骨肉瘤成分表达Vimentin、P120;化生性癌表达CK-P、E-Cad、P120、CK14、CK34、P63;叶状肿瘤梭型间质细胞表达Vimentin、SMA、CD10、CD34、CD117。结论 乳腺骨肉瘤通常为其他类型肿瘤的成分之一,确诊依靠病理;恶性度高,以血道转移为主;乳腺根治切除是主要治疗措施,部分病例化疗或局部放疗可能有效。
Abstract:Objecitve To investigate the clinicopathological characteristics, immunohistochemical expression, diagnosis and differential diagnosis of breast tumors with osteosarcoma differentiation. Methods HE and immunohistochemical staining were performed on 4 cases of malignant breast tumors with osteosarcoma differentiation in the First Affiliated Hospital of Guangxi University of Chinese Medicine.Clinical data were analyzed and the literature were reviewed. Results Among the 4 patients, 2 patients had malignant phyllodes tumor with osteosarcoma differentiation, 1 patient had metaplastic breast carcinomas with osteosarcoma differentiation, and 1 patient had papilloma with osteosarcoma differentiation.Immunohistochemistry:the components of osteosarcoma expressed Vimentin and P120, while the metaplastic carcinoma expressed CK-P, E-Cad, P120, CK14, CK34 and P63.The lobular tumor spindle mesenchymal cells expressed Vimentin, SMA, CD10, CD34, and CD117. Conclusion Breast osteosarcoma is usually one of the components of other types of tumors, and the diagnosis depends on pathology.It is highly malignant and mainly metastases to the bloodstream.Radical mastectomy is the main treatment measure, and chemotherapy or local radiotherapy may be effective in some cases.
文章编号: 中图分类号: 文献标志码:B
基金项目:
Author Name | Affiliation |
HUANG Ke-qiang, CUI Jin-zhu | Department of Pathology, the First Affiliated Hospital of Guangxi University of Chinese Medicine, Nanning, Guangxi 530023, China |
Author Name | Affiliation |
HUANG Ke-qiang, CUI Jin-zhu | Department of Pathology, the First Affiliated Hospital of Guangxi University of Chinese Medicine, Nanning, Guangxi 530023, China |
引用文本: